Diagenode

CRISPR/Cas9 antibodies

RNA-targeting CRISPR antibodies

The latest tool for CRISPR gene editing is a new CRISPR-C2C2 (Cas13a) system which utilizes RNA-guided RNA-targeting for RNA knockdown and binding in cells. C2C2 (Cas13a) may be useful for isolating specific RNA sequences or even studying single RNA molecules with high specificity. Unlike editing DNA as with Cas9 which makes permanent genomic changes,  targeting RNA with C2C2 allows temporarily altering the amount of protein potentially offering a better therapeutic approach in the future. 

Use Diagenode's new C2C2 (Cas13a) polyclonal antibody to determine precision and success metrics in CRISPR experiments.

Products

Cat. No.ProductApplicationPurity
C15310267-100 C2C2 Antibody
(100 μl)
WB Whole antiserum from rabbit containing 0.05% azide.
C15200249 C2C2 Antibody
(50 µg/50 µl)
WB Protein G purified monoclonal antibody
C15100149 LwaCas13a Antibody
(100 µl)
WB Concentrated cell culture supernatant.
C15200250 PspCas13b Antibody
(50 µg)
WB Protein G purified monoclonal antibody.

Events

  • Cours international sur le Génome non-codant 11ème édition
    Paris, France
    May 11-May 18, 2022
  • CLEPIC 2022
    Szczecin, Poland
    Jun 8-Jun 10, 2022
  • European Socienty of Human Genetics - ESHG 2022
    Wien, Austria
    Jun 11-Jun 14, 2022
  • Lausanne Genomics Days 2022
    Lausanne, Switzerland
    Jun 16-Jun 17, 2022
 See all events

News

 See all news


The European Regional Development Fund and Wallonia are investing in your future.

Extension of industrial buildings and new laboratories.


       Site map   |   Contact us   |   Conditions of sales   |   Conditions of purchase   |   Privacy policy   |   Diagenode Diagnostics